ETS Surgery for Hyperhidrosis: Risks, Results, and Alternatives

What Is ETS Surgery?

Endoscopic thoracic sympathectomy (ETS) is a surgical procedure that interrupts the sympathetic nerve chain responsible for triggering excessive sweating. It is the most definitive treatment available for hyperhidrosis — and also the most controversial, because it carries a substantial risk of a side effect that can be worse than the original condition: compensatory sweating.

If you're reading this page, you've likely been struggling with severe hyperhidrosis for years. You may have tried clinical antiperspirants, iontophoresis, Botox, and oral medications without adequate relief. ETS surgery may be on your radar as a last resort.

This article will give you a thorough, honest assessment of ETS — the good, the bad, and the potentially life-altering complications — so you can make a fully informed decision. We strongly recommend exhausting all less invasive treatments before considering surgery. But we also recognize that for a small subset of patients with truly debilitating hyperhidrosis, ETS has been genuinely life-changing.

How ETS Surgery Works

The Sympathetic Nerve Chain

Your sympathetic nervous system runs along both sides of your spine as a chain of nerve bundles (ganglia) connected by nerve fibers. These ganglia relay signals from your brain to various organs, including your sweat glands. Different levels of the chain correspond to different body regions:

• T2 ganglion: Facial and scalp sweating
• T3 ganglion: Palmar (hand) sweating and some facial sweating
• T4 ganglion: Axillary (underarm) sweating and some palmar sweating
• T5 and below: Truncal and lower body sweating

In ETS surgery, the surgeon interrupts the sympathetic chain at the appropriate level to stop sweat signals from reaching the target area.

The Surgical Procedure

ETS is performed under general anesthesia as a minimally invasive thoracoscopic procedure:

1. Access: The surgeon makes 2-3 small incisions (5-10 mm each) in the armpit area or along the side of the chest.

2. Lung deflation: The lung on the operative side is temporarily partially deflated to create working space in the chest cavity. A specialized double-lumen endotracheal tube allows the other lung to continue breathing normally.

3. Visualization: A thoracoscope (tiny camera) is inserted through one incision, providing a magnified view of the sympathetic chain on a monitor.

4. Nerve interruption: The surgeon identifies the target sympathetic ganglia and interrupts the chain using one of several techniques:

   • Cutting (sympathectomy): The nerve is severed — this is irreversible.
   • Clamping (sympathicotomy): Titanium clips are placed on the nerve — potentially reversible if complications occur, though reversal success rates are low.
   • Cauterization: The nerve is destroyed with electrocautery — irreversible.

5. Bilateral procedure: The process is repeated on the other side, either during the same surgery or in a staged procedure weeks later.

6. Re-inflation: The lung is re-inflated, incisions are closed, and the patient is monitored in recovery.

The entire procedure takes approximately 1-2 hours for bilateral treatment.

Recovery Timeline

• Day 1: Hospital stay (typically overnight). Pain managed with oral medications. Chest X-ray to confirm lung re-inflation.
• Day 2-3: Discharge home. Hands may already be noticeably drier.
• Week 1: Moderate chest soreness. Restricted arm movement advised. No heavy lifting.
• Week 2-3: Most patients return to desk work. Pain diminishes significantly.
• Week 4-6: Return to full activity including exercise.
• Month 3-6: Final results stabilized. Compensatory sweating pattern (if present) typically established.

Success Rates

Immediate Results

ETS has impressively high immediate success rates for palmar hyperhidrosis:

• Palmar hyperhidrosis: 95-98% immediate success rate. Patients often wake from surgery with completely dry hands for the first time in their lives.
• Axillary hyperhidrosis: 75-85% success rate. Less predictable than palmar treatment.
• Facial/craniofacial hyperhidrosis: 85-95% success rate for facial sweating and blushing.
• Plantar hyperhidrosis: Not directly treated by ETS (the lumbar sympathetic chain would need to be targeted, which carries even higher risks).

Long-Term Effectiveness

While immediate results are excellent, long-term studies reveal a more nuanced picture:

• Recurrence rate: 2-5% of patients experience some return of sweating within 1-2 years, likely due to nerve regeneration or alternative nerve pathways.
• Sustained satisfaction: At 5-year follow-up, 65-85% of patients report continued satisfaction — a number that's reduced from the immediate post-operative satisfaction rate primarily due to compensatory sweating.
• Regret rate: Studies report that 2-15% of ETS patients regret having the surgery, with compensatory sweating being the primary reason.

The Critical Risk: Compensatory Sweating

What Is Compensatory Sweating?

Compensatory sweating (CS) is the body's response to sympathetic nerve disruption. When the nerve signals to one area are blocked, the body compensates by increasing sweating in untreated areas — most commonly the back, chest, abdomen, groin, and thighs.

This is not a minor footnote. Compensatory sweating is the defining concern of ETS surgery and the primary reason many dermatologists advise against it.

How Common Is It?

The numbers are sobering:

• Any degree of compensatory sweating: 50-97% of patients (depending on the study and how rigorously CS is assessed)
• Moderate compensatory sweating: 30-50% of patients
• Severe compensatory sweating (worse than original condition): 10-25% of patients

A large meta-analysis published in the Annals of Thoracic Surgery reviewing over 3,000 patients found that 86% experienced some degree of compensatory sweating, with 32% rating it as significant.

What Compensatory Sweating Looks Like

At its mildest, compensatory sweating means slightly increased perspiration on your back during exercise — something most people consider an acceptable trade-off for dry hands.

At its worst, compensatory sweating can be devastating. Patient accounts describe:

• Soaked shirts from back and chest sweat within minutes of mild activity
• Constant dampness in the groin area
• Sweating triggered by eating, mild warmth, or any physical exertion
• Sweat that runs in rivulets down the torso
• A condition that is, by the patient's own assessment, worse than what they had before surgery

The cruel irony is that severe compensatory sweating is essentially untreatable. The sweat glands are functioning normally — it's the regulatory signals that are disrupted, and there's no good way to restore them.

Factors Affecting Compensatory Sweating Risk

Research has identified several factors that influence the severity of compensatory sweating:

• Level of nerve interruption: Interrupting higher levels (T2) carries a greater risk of severe CS than lower levels (T4). Modern surgical practice favors T3-T4 sympathectomy to minimize this risk.
• Number of ganglia interrupted: Interrupting multiple levels increases CS risk.
• Body mass index: Higher BMI is associated with more severe CS.
• Climate: Patients in hot, humid climates tend to experience worse CS.
• Pre-operative sweating pattern: Patients who sweat heavily in multiple areas before surgery may be at higher risk.

The Reversibility Question

One reason some surgeons prefer the clamping technique over cutting is the theoretical reversibility — if compensatory sweating is intolerable, the clips can be removed to restore nerve function.

However, the reality is more complicated:

• Reversal success rate: Studies report only 30-50% improvement in compensatory sweating after clip removal.
• Original sweating returns: If reversal is successful in reducing CS, the original palmar hyperhidrosis typically returns as well.
• Time-dependent: Reversal is more likely to succeed if performed within 6-12 months of the original surgery. After prolonged nerve compression, permanent nerve damage may have occurred.
• No guarantees: Some patients see no improvement from reversal.

Other Risks and Complications

Surgical Complications

Like any surgical procedure, ETS carries general risks:

• Pneumothorax (collapsed lung): Occurs in 2-5% of cases. Usually resolves with observation or a chest tube.
• Hemothorax (bleeding into the chest cavity): Rare (under 1%).
• Horner's syndrome (drooping eyelid, constricted pupil): Rare (under 1%), typically from T2 level surgery. May be permanent.
• Intercostal neuralgia (nerve pain along the ribs): Occurs in 1-2% of patients.
• Infection: Rare with minimally invasive technique.

Gustatory Sweating

Approximately 30-50% of ETS patients develop gustatory sweating — sweating triggered by eating, particularly spicy or strongly flavored foods. This is usually mild but can be bothersome.

Cardiac Effects

The sympathetic nervous system also influences heart rate. Some ETS patients report:

• Reduced resting heart rate (decrease of 5-10 BPM on average)
• Reduced heart rate response during exercise — the heart may not accelerate as quickly
• Generally well-tolerated but worth discussing with your cardiologist if you have pre-existing heart conditions or are an athlete

Phantom Sweating

Some patients report a sensation of sweating in the hands despite being objectively dry. This is a neurological artifact and typically fades over time.

When Is ETS Surgery Appropriate?

The Case for Surgery

ETS may be a reasonable consideration when ALL of the following criteria are met:

1. Severity: You have severe primary focal hyperhidrosis (HDSS grade 4) — sweating that is "intolerable and always interferes with daily activities."
2. Treatment failure: You have genuinely tried and failed (or cannot tolerate) the following treatments:
   • Clinical antiperspirants (prescription-strength aluminum chloride)
   • Iontophoresis (for palmar/plantar) — consistent use for at least 6 weeks
   • Botox injections
   • Oral anticholinergic medications
   • Qbrexza wipes (for axillary)
3. Informed consent: You fully understand and accept the risk of compensatory sweating.
4. Quality of life: Your hyperhidrosis causes profound impairment that other treatments cannot adequately address.
5. Body area: Your primary concern is palmar, axillary, or craniofacial hyperhidrosis.

The Case Against Surgery

Many dermatologists and hyperhidrosis specialists strongly advise against ETS. Their arguments include:

• Irreversibility: Once the nerve is cut (or even clamped for an extended period), the damage is difficult or impossible to undo.
• Compensatory sweating: The 50-80%+ risk of new, potentially worse sweating elsewhere is an unacceptable gamble for most patients.
• Better alternatives exist: Modern treatments like Botox, iontophoresis, and medications provide significant relief with far fewer risks.
• Regret rates: Even in studies conducted by surgeons who perform ETS, 2-15% of patients express regret. In patient-reported surveys (which may be more honest), regret rates are sometimes higher.
• Unpredictable outcomes: There's no reliable way to predict who will develop severe compensatory sweating versus mild or none.

The International Hyperhidrosis Society's position is that ETS should be considered only after all other treatment options have been exhausted, and only by patients who are fully informed of the risks.

Choosing a Surgeon

If you decide to proceed with ETS after careful deliberation, surgeon selection is critical:

What to Look For

• Board certification in thoracic surgery
• High volume: The surgeon should perform ETS regularly (at least 20-30 cases per year). ETS outcomes are significantly better with experienced surgeons.
• Modern technique: The surgeon should use sympathicotomy (clamping) at the T3-T4 level as the primary approach, not T2-level cutting. This reflects current best practices for minimizing compensatory sweating.
• Detailed informed consent: A good surgeon will spend significant time discussing compensatory sweating risk and will not minimize it.
• Patient references: Ask to speak with previous patients, including those who experienced compensatory sweating.
• Willingness to turn patients away: The best ETS surgeons will refuse to operate on patients they believe are not appropriate candidates or who haven't exhausted alternatives.

Red Flags

• A surgeon who downplays compensatory sweating risk
• A surgeon who recommends ETS without confirming you've tried other treatments
• A surgeon who routinely targets T2 (higher risk of severe CS)
• A surgeon who performs fewer than 10 ETS procedures per year

Cost of ETS Surgery

| Component | Estimated Cost | |-----------|---------------| | Surgeon's fee | $3,000-$8,000 | | Anesthesia | $1,500-$3,000 | | Hospital/facility fee | $3,000-$8,000 | | Pre-operative evaluation | $200-$500 | | Total | $8,000-$20,000 |

Insurance Coverage

Many insurance plans cover ETS surgery for documented severe hyperhidrosis, particularly when you've demonstrated failure of conservative treatments. You'll typically need:

• A diagnosis of primary focal hyperhidrosis
• Documentation of failed first-line treatments (antiperspirants, Botox, medications)
• A letter of medical necessity from your dermatologist
• Prior authorization from your insurer

When covered, your out-of-pocket cost is typically your deductible plus co-insurance, which may be $1,000-$5,000 depending on your plan.

Alternatives to Exhaust First

Before considering ETS, make absolutely sure you've given these treatments a fair trial:

1. Clinical antiperspirants — Prescription-strength aluminum chloride applied correctly (at night, to dry skin).
2. Iontophoresis — Daily sessions for 4-6 weeks with proper technique. Try glycopyrrolate solution if tap water alone doesn't work. See our guide to the best iontophoresis machines.
3. Botox — At adequate doses, administered by an experienced provider.
4. Oral medications — Glycopyrrolate at therapeutic doses (up to 4 mg/day), oxybutynin as an alternative.
5. Qbrexza wipes — For axillary hyperhidrosis.
6. miraDry — For axillary hyperhidrosis (permanent, non-surgical).
7. Combination therapy — Multiple treatments used together often succeed when individual treatments fail.
8. Natural remedies — As complementary approaches.

For a comprehensive treatment roadmap, see our complete guide to hyperhidrosis.

Frequently Asked Questions

What is the success rate of ETS surgery?

For palmar hyperhidrosis, the immediate success rate is 95-98% — nearly all patients wake up with dry hands. However, long-term satisfaction drops to 65-85% due to compensatory sweating. For axillary hyperhidrosis, success rates are lower (75-85%).

Is ETS surgery reversible?

ETS with clamping is theoretically reversible — the clips can be removed. However, reversal success is limited (30-50% partial improvement), especially if more than 6-12 months have passed. ETS with cutting or cauterization is irreversible.

How bad is compensatory sweating really?

It varies enormously. Some patients experience mild, tolerable sweating on the back that barely affects their lives. Others develop severe, debilitating sweating on the trunk, groin, and legs that they describe as worse than their original condition. The frustrating reality is that there's no reliable way to predict your individual outcome beforehand.

Can ETS treat plantar (foot) hyperhidrosis?

Not directly. The sympathetic nerves to the feet are located in the lumbar region, and lumbar sympathectomy carries even higher risks (including sexual dysfunction) and is very rarely performed. Some patients report indirect improvement in foot sweating after thoracic ETS, but it's inconsistent. Iontophoresis and Botox are better options for plantar hyperhidrosis.

How long is the recovery from ETS surgery?

Most patients return to desk work within 1-2 weeks and full activity within 4-6 weeks. Post-operative pain is generally moderate and well-controlled with oral pain medication. The tiny incisions heal quickly with minimal scarring.

Will my insurance cover ETS surgery?

Many insurance plans cover ETS for documented severe hyperhidrosis when conservative treatments have failed. You'll need documentation from your dermatologist and prior authorization. The specific requirements vary by insurer.

What if I get compensatory sweating — can anything help?

Treatment options for compensatory sweating are limited but include: anticholinergic medications (which you may have already tried), Botox injections in the areas of compensatory sweating, glycopyrrolate-soaked pads, and moisture-wicking clothing. None of these are as effective as the treatments available for primary hyperhidrosis, which is why avoiding compensatory sweating through non-surgical treatment is so preferable.

Do surgeons still recommend ETS?

Opinions are divided. Thoracic surgeons who perform ETS regularly often view it as an appropriate last resort for severe cases. Many dermatologists and hyperhidrosis specialists are more cautious, pointing to the availability of effective non-surgical alternatives and the irreversible risk of compensatory sweating. The trend in recent years has been toward greater caution and lower surgical volumes as non-surgical options have improved.

Sources

1. Cerfolio RJ, et al. "The Society of Thoracic Surgeons expert consensus for the surgical treatment of hyperhidrosis." Annals of Thoracic Surgery. 2011;91(5):1642-1648.
2. Baumgartner FJ, Toh Y. "Severe hyperhidrosis: clinical features and current thoracoscopic surgical management." Annals of Thoracic Surgery. 2003;76(2):491-495.
3. Gossot D, et al. "Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis." Annals of Thoracic Surgery. 2003;75(4):1075-1079.
4. Dewey TM, et al. "One-year follow-up after thoracoscopic sympathectomy for hyperhidrosis: outcomes and consequences." Annals of Thoracic Surgery. 2006;81(4):1227-1232.
5. Campanati A, et al. "Long-term assessment of compensatory sweating in patients with thoracic sympathectomy." Annals of Thoracic Surgery. 2014;97(3):897-901.
6. Henteleff HJ, Kalavrouziotis D. "Evidence-based review of the surgical management of hyperhidrosis." Annals of Thoracic Surgery. 2008;86(1):302-312.
7. International Hyperhidrosis Society. "Endoscopic Thoracic Sympathectomy (ETS)." www.sweathelp.org. Accessed March 2026.